Claudin-5 protein is a new differential marker for histopathological differential diagnosis of canine hemangiosarcoma

Histology and Histopathology

Volumn 24, Issue 7, 2009, Pages 801-813

  Jakab, Cs ^a   Halasz J ^b   Kiss, A ^b   Schaff, Z ^b   Rusvai, M ^a   Galfi P ^a   Abonyi, T Z ^a   Kulka, J ^b  

^a SZENT ISTVÁN UNIVERSITY   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Canine hemangiosarcoma; Canine splenic hematoma; Claudin 5; Differential diagnosis; Immunohistochemistry

Indexed keywords

CLAUDIN 5 PROTEIN, DOG; CLAUDIN-5 PROTEIN, DOG; DIAGNOSTIC AGENT; MEMBRANE PROTEIN; TUMOR MARKER;

ANGIOSARCOMA; ANIMAL; ANIMAL DISEASE; ARTICLE; DIFFERENTIAL DIAGNOSIS; DOG; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; PATHOLOGY; SENSITIVITY AND SPECIFICITY;

ANIMALS; DIAGNOSIS, DIFFERENTIAL; DOGS; FEMALE; HEMANGIOSARCOMA; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE PROTEINS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 68849125515     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Amasheh S., Schmidt T., Mahn M., Florian P., Mankertz J., Tavalali S., Gitter A.H., Schulzke J.D. and Fromm M. (2005). Contribution of claudin-5 to barrier properties in tight junctions of epithelial cells. Cell Tissue Res. 1, 89-96.
2. Anderson J.M. and van Itallie C.M. (1995). Tight junctions and the molecular basis for regulation of paracellular permeability. Am. J. Physiol. 269, 467-475.
3. Aronsohn M. (1985). Cardiac hemangiosarcoma in the dog: A review of 38 cases. J. Am. Vet. Med. Assoc. 187, 922-926.
4. Augustin-Voss H.G., Smith C.A. and Lewis R.M. (1990). Phenotypic characterization of normal and neoplastic canine endothelial cells by lectin histochemistry. Vet. Pathol. 27, 103-109.
5. Brown N.O., Patnaik A.K. and MacEwen E.G. (1985). Canine hemangiosarcoma: Retrospective analysis of 104 cases. J. Am. Vet. Med. Assoc. 186, 56-58.
6. Clifford C.A., Macking A.J. and Henry C.J. (2000). Treatment of canine hemangiosarcoma: 2000 a beyond. J. Vet. Inter. Med. 5, 479-485.
7. Ferrer L., Fondevila D., Rabanal R.M. and Vilafranca M. (1995). Immunohistochemical detection of CD31 antigen in normal and neoplastic canine endothelial cells. J. Comp. Pathol. 112, 319-326.
8. Fosmire S.P., Erin B.D., Allyson M.S., Stacie R.B., Marilyn J.P., Heather M., Marcia P., Ashley A.F.A., Nasim A., David M.G., John W., Matthew B., Stuart C.H. and Jaime F.M. (2004). Canine malignant hemangiosarcoma as a model of primitive angiogenic endothelium. Lab. Invest. 84, 562-572.
9. Frost A.R., Sparks D. and Grizzle W.E. (2000). Methods of antigen recovery vary in their usefulness in unmasking specific antigens in immunohistochemistry. Appl. Immunohistochem. Mol. Morphol. 8, 236-243.
10. Furuse M., Fujita K., Hiiragi T., Fujimoto K. and Tsukita S. (1998). Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J. Cell Biol. 141, 1539-1550.
11. Gonzalez-Mariscal L., Betanzos A., Nava P. and Jaramillo B.E. (2003). Tight junction proteins. Prog. Biophys. Mol. Biol. 81, 1-44.
12. Gumbiner B. (1987). Structure, biochemistry, and assembly of epithelial tight junctions. Am. J. Physiol. 253, 749-758.
13. Hayden D.W., Bartges J.W., Bell F.W. and Klausner J.S. (1992). Prostatic hemangiosarcoma in a dog: clinical and pathologic findings. J. Vet. Diagn. Invest. 4, 209-211.
14. Hammer A.S., Couto C.G., Filppi J., Getzy D. and Shank K. (1991). Efficacy and toxicity of VAC chemotherapy (vincristine, doxorubicin, and cyclophosphamide) in dogs with hemangiosarcoma. J. Vet. Intern. Med. 5, 160-166.
15. Hargis A.M., Ihrke P.J. and Spangler I.W. (1992). A retrospective clinicopathologic study of 212 dogs with cutaneous hemangiomas and hemangiosarcomas. Vet. Pathol. 29, 316-328.
16. Harhaj N.S. and Antonetti D.A. (2004). Regulation of tight junctions and loss of barrier function in pathophysiology. Internat. J. Biochem. Cell Biol. 36, 1206-1237.
17. Jakab Cs., Halász J., Szász A.M., Batmunkh E., Kiss A., Schaff Z., Rusvai M., Gálfi P. and Kulka J. (2008a). Expression and localisation of claudin-1,-2,-3,-4,-5,-7 and -10 proteins in the normal canine mammary gland. Acta Vet. Hung. 56, 341-352.
18. Jakab Cs., Halász J., Szász A.M., Kiss A., Schaff Z., Rusvai M., Abonyi T.Zs. and Kulka J. (2008b). Evaulation of microvessel density (MVD) in canine mammary tumours by quantitative claudin-5 molecule immunohistochemistry. Acta Vet. Hung. 56, 495-510.
19. Kamimura Y., Chiba H., Utsumi H., Gotoh T., Tobioka H. and Sawada N. (2002). Barrier function of microvessels and roles of glial cell linederived neurotrophic factor in the rat testis. Med. Electron Microsc. 35, 139-145.
20. Kanda T., Numata Y. and Mizusawa H. (2004). Chronic inflammatory demyelinating polyneuropathy: decreased claudin-5 and relocated ZO-1. J. Neurol. Neurosurg. Psych. 75, 765-769.
21. Kojima S., Rahner C., Peng S. and Rizzolo L.J. (2002). Claudin 5 Is transiently expressed during the development of the retinal pigment epithelium. J. Membr. Biol. 2, 81-88.
22. Kuzu I., Bicknell R., Fletcher C.D and Gatter K.C. (1993). Expression of adhesion molecules on the endothelium of normal tissues vessels and vascular tumors. Lab. Invest. 69, 322-328.
23. Little D., Said T.W., Siegel R.J., Fealy M. and Fishbein M.C. (1986). Endothelial cell markers in vascular neoplasms: an immunohistochemical study comparing factor VIII-related antigen, blood group spesific antigens, 6-keto-PGF1 alpha and Ulex europaeus 1 lectin. J. Pathol. 149, 89-95.
24. Martin T.A., Das T., Mansel R.E. and Jiang W.G. (2006). Synergistic regulation of endothelial tight junctions by antioxidant (Se) and polyunsaturated lipid (GLA) via claudin-5 modulation. J. Cell. Biochem. 98, 1308-1319.
25. McGavin M.D. and Zachary F.J. (2007). Pathologic basis of veterinary disease. 4th edition. Mosby Elsevier. pp 814-817.
26. Montero C. (2003). The antigen-antibody reaction in immunohistochemistry. J. Histochem. Cytochem. 51, 1-4.
27. Moore H.S., Madewell B.R. and Lund J.K. (1989). Immunohistochemical evaluation of intermediate filament expression in canine and feline neoplasms. Am. J. Vet. Res. 50, 88-92.
28. Morita K., Sasaki H., Furuse M. and Tsukita S. (1999). Endothelial claudin: claudin-5/TMVCF constitutes tight junction strands inendothelial cells. J. Cell Biol. 147, 185-194.
29. Morita K., Sasaki H., Furuse M., Tsukita S. and Miyachi, Y. (2003). Expression of claudin-5 in dermal vascular endothelia. Experim. Derm. 12, 289- 295.
30. Muller W.A. AS9. (1997). CD31 workshop panel report. In: Leucocyte typing VI. White cell differentiation antigens. Proceedings of the 6th International Workshop and Conference; 1996 Nov 10-14; Kobe, Japan.
31. Kishimoto T., Kikutani H., von dem Borne A.E.G., Goyert S.M., Mason D.Y. and Miyasaka M. (eds). Garland Publishing Inc. New York. London. pp 362-364.
32. Nitta T., Hata M., Gotoh S., Seo Y., Sasaki H., Hashimoto N., Furuse M. and Tsukita S. (2003). Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J. Cell Biol. 3, 653-661.
33. Parums D.V., Cordell J.L., Micklem F., Heryet A.R., Gatter K.C. and Masons D.Y. (1990). JC70: a new monoclonal antibody that detects vascular endothelium associated antigen on rountinely processed tissue sections. J. Clin. Pathol. 43, 752-57.
34. Rahner C., Mitic L.L. and Anderson J.M. (2001). Heterogeneity in expression and subcellular localization of claudins 2, 3, 4, and 5 in the rat liver, pancreas, and gut. Gastroenterology 120, 411-422.
35. Ramos-Vara J.A. (2005). Techical aspects of immunohistochemistry. Vet. Pathol. 42, 405-426.
36. Rhind S.M. (2002). Veterinary oncological pathology: current and future perspectives. Vet. J. 163, 7-18.
37. Ruiz F.S., Alessi A.C., Chagas C.A., Pinto G.A. and Vassallo J. (2005). Immunohistochemistry in diagnostic veterinary pathology: a critical review. J. Bras. Pathol. Med. Lab. 41, 163-170.
38. Schneeberger E.E. and Lynch R.D. (1992). Structure, function and regulation of cellular tight junctions. Amer. J. Physiol. 262, 647-661.
39. Shi S., Cote R.J. and Taylor C.R. (2001). Antigen retrieval immunohistochemistry and molecular morphology in the year. Appl. Immunohistochem. Mol. Morphol. 9, 107-116.
40. Shi S.R., Gu J., Turrens J., Cote R.J. and Taylor C.R. (2000). Development of the antigen retrieval technique: philosophical and theoretical bases. In: antigen retrieval techniques: Immunohistochemistry and molecular morphology. Shi S-R., Gu J. and Taylor C.R. (eds). Eaton Publishing. Natick, MA. pp 17-40.
41. Sirotkin H., Morrow B., Saint-Jore B., Puech A., Das Gupta R., Patanjali S.R., Skoultchi A., Weissman S.M. and Kucherlapati R. (1997). Identification, characterization, and precise mapping of a human gene encoding a novel membrane-spanning protein from the 22q11 region deleted in velo-cardiofacial syndrome. Genomics 42, 245-251.
42. Smith A.N. (2003). Hemangiosarcoma in dogs and cats. In: The veterinary clinics of North America, small animal practice, advances in medical oncology. W.B. Saunders Co. Philadelphia. pp 533-552.
43. Soini Y. (2005). Expression of claudins 1, 2, 3, 4, 5 and 7 in various types of tumours. Histopathology 46, 551-560.
44. Sorenmo K.U., Duda L., Barber L., Cronin K., Sammarco C., Usborne A., Goldschmidt M. and Shofer F.S. (2000). Canine hemangiosarcoma treated with standard chemotherapy and minocycline. J. Vet. Intern. Med. 14, 395-398.
45. Sorenmo K.U., Jeglum K.A. and Helfand S.C. (1993). Chemotherapy of canine hemangiosarcoma with doxorubicin and cyclophosphamide. J. Vet. Intern. Med. 7, 370-376.
46. Yang Y., Estradal E.Y., Thompsonl J.F., Liu W. and Rosenberg G.A. (2007). Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J. Cereb. Blood Flow Metab. 27, 697-709.
47. Yonemaru K., Sakai H., Muramaki M., Yanai T. and Masegi T. (2006). Expression of vascular growth factor, basic fibroblast factor, and their receptors (flt-1, flk-1, and flg-1) in canine vascular tumors. Vet. Pathol. 43, 971-980.
48. Von Beust B.R., Suter M.M. and Summer B.A. (1988). Factor VIIIrelated antigen in canine endothelial neoplasms: an immunohistochemical study. Vet. Pathol. 25, 251-255.
49. Wang F.I. and Su H.L. (2001). A renal hemangiosarcoma causing a hematuria in a dog. Proc. Natl. Sci. Counc. 3, 187-192
50. Ward H., Fox L.E., Calderwood-Mays M.B., Hammer A.S. and Cuoto C.G. (1994). Cutaneous hemangiosarcoma in 25 dogs: A retrospective study. J. Vet. Intern. Med. 8, 345-348.
51. Withrow S.J. and MacEwen E.G. (2001). Small animal clinical oncology. 3rd ed. W. B. Saunders Co. Philadelphia. PA. pp 639-645.